HALO logo
halo search icon
CINPHA
Cinclus Pharma Holding AB

CINPHA · Cinclus Pharma Holding AB

13.20

SEK
0.00 (0.00%)
24/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr614.30M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden.

  • All-Companies
  • All-Consensus
  • HALO All
  • HALO Balance Sheet
  • HALO Consensus Value
  • Recent Earnings upgrade
  • Recent Price upgrade

Key Fundamentals

EPS 3 yr Growth

-99.50%

EBITDA Margin

-340.70%

Operating Cashflow

-kr75m

Free Cash Flow Return

-16.10%

ROIC

-39.60%

Interest Coverage

-495.70

Quick Ratio

3.90

Performance

52 weeks range

Low 10.48 - 19.64

Trade Value (12mth)

US$25,631.00

1 week

11.68%

1 month

10.55%

YTD

-31.25%

1 year

-16.56%

All time high

40.00

Additional Data

Shares Outstanding (Fully Diluted)

47m

HALO Sector

Healthcare

Next Company Report Date

17-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

SEK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Trill Impact Ventures Pharma 1 ABPrivate Company
Chesnara PlcPublic Company
Linc ABPublic Company
Peter UngeIndividual
Kjell AnderssonIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Cinclus Pharma Holding AB (CINPHA:OME)?
Halo FAQ
The current share price of Cinclus Pharma Holding AB (CINPHA:OME) is SEKkr13.20.
2
What is the 52-week high share price for Cinclus Pharma Holding AB (CINPHA:OME)?
Halo FAQ
The 52-week high share price for Cinclus Pharma Holding AB (CINPHA:OME) is SEKkr19.64.
3
What is the 52-week low share price for Cinclus Pharma Holding AB (CINPHA:OME)?
Halo FAQ
The 52-week low share price for Cinclus Pharma Holding AB (CINPHA:OME) is SEKkr10.48.
4
What is the dividend yield for Cinclus Pharma Holding AB (CINPHA:OME)?
Halo FAQ
Cinclus Pharma Holding AB (CINPHA:OME) does not pay a dividend.
5
What was Cinclus Pharma Holding AB (CINPHA:OME) last dividend payment?
Halo FAQ
Cinclus Pharma Holding AB (CINPHA:OME) does not pay a dividend.
6
What is the franking level for Cinclus Pharma Holding AB (CINPHA:OME)?
Halo FAQ
Cinclus Pharma Holding AB (CINPHA:OME) has a franking level of 0.00%.
7
In which sector is Cinclus Pharma Holding AB (CINPHA:OME) classified?
Halo FAQ
Cinclus Pharma Holding AB (CINPHA:OME) is classified in the Healthcare.